Beijing Tongrentang is a well-known brand in Chinese medicine industry. Founded in 1669 (the eighth year of Emperor Kangxi in Qing Dynasty), it devoted itself to imperial doctors from 1723, and experienced eight emperors 188. In the course of more than 300 years, Tongrentang people in past dynasties have always adhered to the old adage that "although the processing is complicated, they will not dare to save labor, and although the taste is expensive, they will not dare to cut materials", and they have established the self-discipline consciousness of "no one sees the combination, but God knows it", which has created the rigorous spirit of being meticulous and improving in the pharmaceutical process. Its products are famous at home and abroad for their unique formula, excellent materials, exquisite technology and remarkable curative effect.

As the first well-known trademark in China, Tongrentang enjoys a unique brand advantage. The countries participating in the Madrid Convention and the Paris Convention are registered and protected by international organizations. Registered in more than 50 countries and regions around the world, it is the first mainland trademark registered in Taiwan Province Province.

1992, approved by Beijing Municipal Government, China Beijing Tongrentang Group Company was established. Beijing Tongrentang Co., Ltd. was established exclusively from 1997 and successfully listed in June of the same year. Since 1999, it has been selected as the "Top 50 Listed Companies with the Most Development Potential in China" for seven consecutive years, ranking first in 2000/kloc-0 and 2002. In 2000, Beijing Tongrentang Co., Ltd. spun off 654.38 billion yuan of high-quality assets with high technology content and established Beijing Tongrentang Technology Development Co., Ltd., becoming the first enterprise in China to use the same state-owned assets for two times of financing, and listed in Hong Kong, which was called "Tongrentang Model" by the industry. The stock of Tongrentang Technology Company has always been one of the best performing stocks in Hong Kong Growth Enterprise Market.

200 1 China Beijing Tongrentang Group Company was transformed into China Beijing Tongrentang (Group) Co., Ltd. In 2002, Tongrentang Group was recommended by the National Federation of Industrial Economics and the Brand Strategy Promotion Committee as one of the most influential enterprises in the world. The Propaganda Department of the Communist Party of China was rated as an advanced unit in spiritual civilization construction. In 2004, it was identified as one of the top ten state-owned enterprises by the Propaganda Department of the CPC Central Committee and the State-owned Assets Supervision and Administration Commission of the State Council.

Since the Ninth Five-Year Plan, Tongrentang has maintained an average annual growth rate of about 20%. In 2004, Tongrentang's total assets reached 6.3 billion yuan, with sales of 5 billion yuan and profits of 340 million yuan. At present, Tongrentang's sales terminal network is spread all over the world, with more than 400 branches, chain stores and shop-in-shop stores. Among them, there are 17 joint ventures and stores in 12 countries and regions. In June, 2004, we bought 1. 1.7 million square meters of land in Hong Kong, invested1.50 million Hong Kong dollars, and established Tongrentang Chinese Medicine Co., Ltd., an overseas production base, which laid a good foundation for the internationalization of production, R&D and marketing. In 2004, the joint-stock company production base, technology company production base and logistics distribution center invested 600 million yuan in Yizhuang Economic and Technological Development Zone have been completed and put into operation. This is the project with the largest investment scale and the highest level of production modernization in Tongrentang history. From automatic control of preparation process, production equipment and management system to energy control, environmental protection and construction quality, it has achieved "six first-class" and is at the leading level in the same industry in China. At present, Tongrentang has formed a pharmaceutical production group consisting of five production bases located in Daxing, Yizhuang, Liujiayao, Tongzhou and Changping, with 4/kloc-0 production lines, which can produce 26 dosage forms and 1 10,000 products.

In the main producing areas of traditional Chinese medicine in China, Tongrentang has 12 green Chinese herbal medicine planting bases jointly built according to national GAP standards, with a total investment of 58 million yuan (including 29.58 million yuan invested by Tongrentang). Tongrentang will become a manufacturer and market supplier of medicinal materials on the basis of realizing the supply of raw materials for its main products.

200 1, in cooperation with the State Council Development Research Center, formulate the development plan of Tongrentang in the next ten years. Based on the principles of independent operation, focusing on each other, sharing resources and overall development, the supporting "1032" project has also made substantial progress. "10" refers to 10 big companies including two listed companies; "32" refers to two hospitals (Tongrentang Research Institute and Tongrentang Chinese Medicine Hospital), two bases (Tongrentang Co., Ltd. and Tongrentang Technology Company's production bases in Yizhuang respectively) and two centers (Tongrentang Training Center and Tongrentang Information Center). At present, Tongrentang has basically formed the industrial layout of pharmaceutical industry, retail business and medical services.

Facing the new situation of world economic integration, Tongrentang's development strategy is to develop a life and health industry with modern Chinese medicine as the core and become an internationally renowned Chinese medicine group. (Reference:

Baidu Encyclopedia)